| Cancer patients and research during COVID-19 pandemic: A systematic review of current evidence E Moujaess, HR Kourie, M Ghosn Critical reviews in oncology/hematology 150, 102972, 2020 | 260 | 2020 |
| ASCEND-8: a randomized phase 1 study of ceritinib, 450 mg or 600 mg, taken with a low-fat meal versus 750 mg in fasted state in patients with anaplastic lymphoma kinase (ALK … BC Cho, DW Kim, A Bearz, SA Laurie, M McKeage, G Borra, K Park, ... Journal of Thoracic Oncology 12 (9), 1357-1367, 2017 | 190 | 2017 |
| Effect of oral eliglustat on splenomegaly in patients with Gaucher disease type 1: the ENGAGE randomized clinical trial PK Mistry, E Lukina, HB Turkia, D Amato, H Baris, M Dasouki, M Ghosn, ... Jama 313 (7), 695-706, 2015 | 169 | 2015 |
| Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE) T Bachelot, E Ciruelos, A Schneeweiss, F Puglisi, T Peretz-Yablonski, ... Annals of Oncology 30 (5), 766-773, 2019 | 107 | 2019 |
| Cancer incidence in postwar Lebanon: findings from the first national population-based registry, 1998 A Shamseddine, AM Sibai, N Gehchan, B Rahal, N El-Saghir, M Ghosn, ... Annals of epidemiology 14 (9), 663-668, 2004 | 99 | 2004 |
| Outcomes after 18 months of eliglustat therapy in treatment‐naïve adults with G aucher disease type 1: The phase 3 ENGAGE trial PK Mistry, E Lukina, H Ben Turkia, SP Shankar, H Baris, M Ghosn, ... American journal of hematology 92 (11), 1170-1176, 2017 | 93 | 2017 |
| FOLFOX-6 combination as the first-line treatment of locally advanced and/or metastatic pancreatic cancer M Ghosn, F Farhat, J Kattan, F Younes, W Moukadem, F Nasr, G Chahine American journal of clinical oncology 30 (1), 15-20, 2007 | 73 | 2007 |
| Anal cancer treatment: current status and future perspectives M Ghosn, HR Kourie, P Abdayem, J Antoun, D Nasr World Journal of Gastroenterology: WJG 21 (8), 2294, 2015 | 67 | 2015 |
| Road map for pain management in pancreatic cancer: a review MJ Lahoud, HR Kourie, J Antoun, L El Osta, M Ghosn World journal of gastrointestinal oncology 8 (8), 599, 2016 | 57 | 2016 |
| The therapeutic use of human albumin in cancer patients’ management E Moujaess, M Fakhoury, T Assi, H Elias, F El Karak, M Ghosn, J Kattan Critical reviews in oncology/hematology 120, 203-209, 2017 | 52 | 2017 |
| Metastatic gastric cancer treatment: Second line and beyond M Ghosn, S Tabchi, HR Kourie, M Tehfe World journal of gastroenterology 22 (11), 3069, 2016 | 48 | 2016 |
| Phase II trial of capecitabine and vinorelbine as first-line chemotherapy for metastatic breast cancer patients M Ghosn, J Kattan, F Farhat, F Younes, J Gasmi Anticancer research 26 (3B), 2451-2456, 2006 | 48 | 2006 |
| Gemcitabine plus carboplatin combination therapy as second-line treatment in patients with relapsed breast cancer FL Nasr, GY Chahine, JG Kattan, FS Farhat, WT Mokaddem, EA Tueni, ... Clinical Breast Cancer 5 (2), 117-122, 2004 | 47 | 2004 |
| Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a … D Miles, E Ciruelos, A Schneeweiss, F Puglisi, T Peretz-Yablonski, ... Annals of Oncology 32 (10), 1245-1255, 2021 | 46 | 2021 |
| Perceptions of the COVID-19 vaccine among patients with cancer: a single-institution survey E Moujaess, NB Zeid, R Samaha, J Sawan, H Kourie, C Labaki, R Chebel, ... Future Oncology 17 (31), 4071-4079, 2021 | 44 | 2021 |
| Abridged geriatric assessment is a better predictor of overall survival than the Karnofsky Performance Scale and Physical Performance Test in elderly patients with cancer M Ghosn, T Ibrahim, E El Rassy, N Nassani, S Ghanem, T Assi Journal of geriatric oncology 8 (2), 128-132, 2017 | 39 | 2017 |
| Dilemma of first line regimens in metastatic pancreatic adenocarcinoma M Ghosn, T Ibrahim, T Assi, E El Rassy, HR Kourie, J Kattan World journal of gastroenterology 22 (46), 10124, 2016 | 39 | 2016 |
| Personalized treatment in metastatic triple‐negative breast cancer: The outlook in 2020 HA Azim, M Ghosn, K Oualla, L Kassem The breast journal 26 (1), 69-80, 2020 | 37 | 2020 |
| PET/CT scanner and bone marrow biopsy in detection of bone marrow involvement in diffuse large B-cell lymphoma F El Karak, IR Bou-Orm, M Ghosn, J Kattan, F Farhat, T Ibrahim, M Jreige, ... PloS one 12 (1), e0170299, 2017 | 35 | 2017 |
| Where does chemotherapy stands in the treatment of ampullary carcinoma? A review of literature M Ghosn, HR Kourie, E El Rassy, FG Haddad, C Hanna, F El Karak, ... World journal of gastrointestinal oncology 8 (10), 745, 2016 | 35 | 2016 |
